HeimONC • NASDAQ
add
Beigene Ltd
255,86 $
Eftir lokun(0,00%)0,00
255,86 $
Lokað: 6. jún., 17:59:48 GMT-4 · USD · NASDAQ · Lagalegir fyrirvarar
Við síðustu lokun
257,00 $
Dagbil
250,00 $ - 257,61 $
Árabil
172,67 $ - 287,88 $
Markaðsvirði
32,11 ma. USD
Meðalmagn
348,44 þ.
Í fréttum
Fjármál
Rekstrarreikningur
Tekjur
Nettótekjur
| (USD) | mar. 2025info | Breyting á/á |
|---|---|---|
Tekjur | 1,12 ma. | 48,64% |
Rekstrarkostnaður | 941,18 m. | 5,98% |
Nettótekjur | 1,27 m. | 100,51% |
Hagnaðarhlutfall | 0,11 | 100,33% |
Hagnaður á hvern hlut | 0,01 | 100,41% |
EBITDA | 42,73 m. | 118,01% |
Virkt skatthlutfall | 93,92% | — |
Efnahagsreikningur
Heildareignir
Heildarskuldir
| (USD) | mar. 2025info | Breyting á/á |
|---|---|---|
Reiðufé og skammtímafjárfestingar | 2,52 ma. | -9,91% |
Heildareignir | 5,84 ma. | 3,07% |
Heildarskuldir | 2,34 ma. | 1,50% |
Eigið fé alls | 3,50 ma. | — |
Útistandandi hlutabréf | 107,95 m. | — |
Eiginfjárgengi | 7,93 | — |
Arðsemi eigna | 0,47% | — |
Ávöxtun eigin fjár | 0,62% | — |
Peningaflæði
Breyting á handbæru fé
| (USD) | mar. 2025info | Breyting á/á |
|---|---|---|
Nettótekjur | 1,27 m. | 100,51% |
Handbært fé frá rekstri | 44,08 m. | 114,29% |
Reiðufé frá fjárfestingum | -121,94 m. | 41,89% |
Reiðufé frá fjármögnun | -33,78 m. | -120,81% |
Breyting á handbæru fé | -108,16 m. | 71,43% |
Frjálst peningaflæði | -145,31 m. | 62,90% |
Um
BeOne Medicines, formerly known as BeiGene, Ltd. is a multinational oncology company. It specializes in the development of drugs for cancer treatment.
Founded in 2010 by chief executive officer John V. Oyler and Xiaodong Wang, the company is headquartered in Cambridge, Massachusetts and has locations on six continents, in over 45 countries. BeOne has a large presence in the Chinese market.
BeOne Medicines has developed several medicines, including tislelizumab, a checkpoint inhibitor, and zanubrutinib, a Bruton's tyrosine kinase inhibitor. On 14 November 2024 the company announced its intention to rebrand as BeOne Medicines. BeOne changed its stock ticker to ONC in January 2025 and redomiciled to Basel, Switzerland in May 2025. Wikipedia
Framkvæmdastjóri
Stofnsett
28. okt. 2010
Vefsvæði
Starfsfólk
11.000
